Dominic Denk is an expert in Gastroenterology at University Hospital Frankfurt (Germany). Dominic Denk has authored 12 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 110 (community average: 125). How the SLR is computed.

LeadR Profile

Dominic Denk University Hospital Frankfurt Germany
110 ScienceLeadR Reputation 110
Network Map

Gastroenterology

Subspecialties: Hepatology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2019 - 2026

Source: PubMed

University Hospital Frankfurt

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 12

Citations

Citations: 417 1st author: 6 Last author: 0 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma.
PMID 41704422 — genes, myc, cells, confidence intervals, carcinoma, hepatocellular, growth, neoplasms, immune checkpoint inhibitors, therapeutics
JHEP Rep20260
Author Correction: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial.
PMID 41491872 — aging, mitophagy
Nat Aging20260
Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial.
PMID 41174221 — cells, monocytes, microscopy, electron, scanning transmission, aging, stem cells, therapeutics, mitophagy, t-lymphocytes
Nat Aging20250
IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis.
PMID 40023157 — cells, mycobiome, neoplasms, immunotherapy, carcinogenesis, immunity, colorectal neoplasms, syk kinase, colonic neoplasms
Immunity Top journal20259
Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.
PMID 38889481 — blood, neuropilins, biomedical research, neoplasms, prostate, neuropilin-1, liver, prostatic neoplasms
EBioMedicine20242

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map